布地奈德辅助治疗小儿肺炎随机对照试验报告摘要质量评价

目的：评价布地奈德辅助治疗小儿肺炎随机对照试验（RCTs）报告摘要质量及分析其影响因素。方法：采用CONSORT 2010申明的临床报告摘要质量评价系统,对中文发表的布地奈德雾化吸入辅助治疗小儿肺炎的RCTs文献摘要进行评价,采用RevMan 5.3软件进行统计学分析。结果：纳入的282篇RCTs摘要报告率低的条目有：“题目判定为随机”“通讯作者”“随机化”“盲法”“随机分组例数” “资助”,且所有文献均无“试验注册”,分层分析中摘要字数对条目报告的影响最大。结论：布地奈德治疗小儿肺炎的RCTs摘要质量与CONSORT 2010申明的临床报告摘要质量存在较大差距,研究人员在今后的文章中应使用CONSORT 规定的条目进行书写以提高摘要质量,增强可读性。

Academic level assessment of randomized controlled trial abstracts in papers on budesonid adjuvant therapy for children pneumonia

Objective To assess the academic level of randomized controlled trial abstracts in papers on budesonid adjuvant therapy for children pneumonia and analyze its influencing factors.Methods The randomized controlled trial abstracts in papers on budesonid adjuvant therapy for children pneumonia were assessed according to the CONSORT 2010 Statement and were statistically analyzed using the RevMan 5.3.Results The items with a low reporting rate of the randomized controlled trial abstracts in the 282 papers included in this paper were "title judged as random", "communication author", "randomized", "blind method", "randomized grouping cases", "fund-supported". Hierarchical analysis showed that the number of words in abstracts played an important role in affecting the reported items.Conclusion The academic level of randomized controlled trial abstracts in papers on budesonid adjuvant therapy for children pneumonia is significantly different from that of the abstracts in clinical papers according to the CONSORT 2010 Statement. Researchers should thus use the CONSORT 2010 Statement-defined items in writing their papers in order to improve the academic level and readability of their abstracts.